Anticancer therapy anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells HeLa Cells Neoplastic Stem Cells Cell Line HT29 Cells MCF-7 Cells Mitochondria Fibroblasts Cells, Cultured HL-60 Cells Hep G2 Cells K562 Cells Endothelial Cells Telomere KB Cells

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL Taxus

Diseases33

Neoplasms Radiation Injuries Breast Neoplasms Neovascularization, Pathologic Lung Neoplasms Radiation Injuries, Experimental Colonic Neoplasms Neoplasms, Experimental Radiation Pneumonitis Neoplasms, Radiation-Induced Melanoma, Experimental Brain Neoplasms Cell Transformation, Neoplastic Adenocarcinoma Glioblastoma Carcinoma, Squamous Cell Prostatic Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Melanoma Acute Radiation Syndrome Pancreatic Neoplasms Colorectal Neoplasms Leukemia P388 Carcinoma Disease Models, Animal Neoplasm Invasiveness Kidney Neoplasms Leukemia L1210 Head and Neck Neoplasms Ovarian Neoplasms Glioma Radiodermatitis

Chemicals and Drugs98

Antineoplastic Agents Antineoplastic Agents, Phytogenic Doxorubicin Antibiotics, Antineoplastic Cisplatin Paclitaxel Etoposide Drug Carriers Tumor Suppressor Protein p53 Angiogenesis Inhibitors Enzyme Inhibitors Ellipticines Camptothecin RNA, Small Interfering Radiation-Sensitizing Agents Proto-Oncogene Proteins c-bcl-2 Caspases Fluorouracil P-Glycoprotein Neoplasm Proteins Protein Kinase Inhibitors Plant Extracts Prodrugs Proteasome Inhibitors Boronic Acids Pyrazines DNA Topoisomerases, Type II Histone Deacetylase Inhibitors Protein-Serine-Threonine Kinases Topoisomerase I Inhibitors Piperazines Daunorubicin RNA, Messenger TNF-Related Apoptosis-Inducing Ligand Platinum Antibodies, Monoclonal Antimetabolites, Antineoplastic Radiation-Protective Agents Hydroxamic Acids Proto-Oncogene Proteins c-akt DNA-Binding Proteins Receptor, Epidermal Growth Factor Nanocapsules Caspase 3 bcl-2-Associated X Protein DNA Telomerase Pyrimidines Cell Cycle Proteins TOR Serine-Threonine Kinases Organoplatinum Compounds Antineoplastic Agents, Alkylating Anticarcinogenic Agents Topoisomerase Inhibitors Benzamides Intercalating Agents Tumor Markers, Biological Proteasome Endopeptidase Complex Drugs, Investigational Mitoxantrone Mitomycin Xanthones Tubulin Modulators Quinazolines DNA Adducts Multidrug Resistance-Associated Proteins Coordination Complexes Antibodies, Monoclonal, Humanized Oligopeptides Tumor Suppressor Proteins DNA Topoisomerases, Type I Reactive Oxygen Species Bleomycin Razoxane ATP-Binding Cassette Transporters Vascular Endothelial Growth Factor A Vinblastine Cobalt Radioisotopes Triterpenes Proto-Oncogene Proteins Liposomes Nuclear Proteins Adjuvants, Pharmaceutic Protease Inhibitors Sirolimus Triazines Benzoquinones Indoles Teniposide Curcumin Naphthoquinones Vincristine Poly(ADP-ribose) Polymerases Depsipeptides Topotecan Vinca Alkaloids Topoisomerase II Inhibitors Deoxycytidine

Analytical, Diagnostic and Therapeutic Techniques and Equipment49

Radiation Dosage Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Xenograft Model Antitumor Assays Drug Delivery Systems Radiation Monitoring Molecular Targeted Therapy Drug Design Neoplasm Transplantation Drug Carriers Combined Modality Therapy Inhibitory Concentration 50 Radiation Injuries, Experimental Transplantation, Heterologous Tumor Burden Models, Biological Neoplasms, Experimental Antineoplastic Combined Chemotherapy Protocols Blotting, Western Clinical Trials as Topic Flow Cytometry Radiotherapy Melanoma, Experimental Radiometry Transfection Drug Evaluation, Preclinical Radiotherapy Dosage Treatment Outcome Genetic Therapy Drug Discovery Nanocapsules Models, Molecular Reverse Transcriptase Polymerase Chain Reaction Oncolytic Virotherapy Clinical Trials, Phase I as Topic Gene Knockdown Techniques Phytotherapy Immunohistochemistry Gene Expression Profiling Radiotherapy, Conformal Tumor Stem Cell Assay Radiation Hybrid Mapping Disease Models, Animal Immunotherapy Dose Fractionation Prognosis Radiotherapy, Intensity-Modulated Oligonucleotide Array Sequence Analysis Brachytherapy

Phenomena and Processes52

Radiation, Ionizing Radiation Dosage Apoptosis Radiation Tolerance Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Radiation Cell Survival Cell Proliferation DNA Damage Gene Expression Regulation, Neoplastic Cell Cycle Drug Synergism Dose-Response Relationship, Drug Molecular Structure Signal Transduction Inhibitory Concentration 50 Gamma Rays Cosmic Radiation Cell Death Drug Resistance, Multiple Time Factors Cell Division Down-Regulation Background Radiation Ultraviolet Rays Autophagy Transfection Radiation Effects Mutation Cell Growth Processes DNA Repair Phosphorylation Up-Regulation Enzyme Activation Cell Hypoxia RNA Interference Structure-Activity Relationship Drug Interactions Tumor Microenvironment Cell Cycle Checkpoints DNA Adducts X-Rays Gene Expression Protein Binding Drug Resistance Genes, MDR Particle Size G2 Phase Telomere Cell Movement Linear Energy Transfer

Disciplines and Occupations7

Drug Design Nanomedicine Radiation Oncology Drug Discovery Immunohistochemistry Radiobiology Pharmacogenetics

Technology, Industry, Agriculture5

Nanomedicine Nanoparticles Nanocapsules Liposomes Nanostructures

Information Science3

Molecular Sequence Data Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care14

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Clinical Trials as Topic Ultraviolet Rays Radiation Effects Treatment Outcome Acute Radiation Syndrome Clinical Trials, Phase I as Topic Radioactive Hazard Release

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents Neoplasms Cell Line, Tumor Radiation, Ionizing Radiation Dosage Drug Screening Assays, Antitumor Radiation Injuries Apoptosis Radiation Tolerance Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Antineoplastic Agents, Phytogenic Doxorubicin Radiation Cell Survival Xenograft Model Antitumor Assays Drug Delivery Systems Mice, Nude Radiation Protection Radiation Monitoring Antibiotics, Antineoplastic Cell Proliferation Tumor Cells, Cultured Cisplatin Molecular Targeted Therapy DNA Damage Drug Design Gene Expression Regulation, Neoplastic Cell Cycle Drug Synergism Breast Neoplasms Dose-Response Relationship, Drug Molecular Structure Paclitaxel Etoposide Nanomedicine Neoplasm Transplantation Signal Transduction Radiation Oncology Drug Carriers Tumor Suppressor Protein p53 Angiogenesis Inhibitors Combined Modality Therapy Inhibitory Concentration 50 Enzyme Inhibitors Ellipticines Gamma Rays Cosmic Radiation Neovascularization, Pathologic Lung Neoplasms Radiation Injuries, Experimental Cell Death Camptothecin RNA, Small Interfering Radiation-Sensitizing Agents Transplantation, Heterologous Proto-Oncogene Proteins c-bcl-2 Tumor Burden Models, Biological Colonic Neoplasms Neoplasms, Experimental Caspases HCT116 Cells Antineoplastic Combined Chemotherapy Protocols Radiation Pneumonitis Blotting, Western Fluorouracil Drug Resistance, Multiple Time Factors P-Glycoprotein Neoplasm Proteins Clinical Trials as Topic Protein Kinase Inhibitors Flow Cytometry Cell Division Neoplasms, Radiation-Induced Radiotherapy Plant Extracts Down-Regulation Prodrugs Background Radiation Mice, SCID Proteasome Inhibitors Ultraviolet Rays Mice, Inbred BALB C Boronic Acids Pyrazines HeLa Cells Autophagy DNA Topoisomerases, Type II Melanoma, Experimental Histone Deacetylase Inhibitors Protein-Serine-Threonine Kinases Radiometry Topoisomerase I Inhibitors Nanoparticles Brain Neoplasms Transfection Drug Evaluation, Preclinical Radiotherapy Dosage

No FAQ available that match "anticancer therapy anticancer drugs or radiation"